✦ LIBER ✦

A Phase II Study of Capecitabine Plus Oxaliplatin (XELOX): A New First-Line Option in Metastatic Colorectal Cancer

✍ Scribed by Makatsoris, Thomas ;Kalofonos, Haralabos P. ;Aravantinos, Gerasimos ;Papadimitriou, Christos ;Kastritis, Efstathios ;Rigatos, Sotirios K. ;Xiros, Nikolaos ;Petsas, Theodore ;Economopoulos, Theofanis ;Sakadamis, Athanassios K. ;Fountzilas, George

Book ID: 111638945
Publisher: Springer
Year: 2005
Tongue: English
Weight: 93 KB
Volume: 35
Category: Article
ISSN: 1537-3649
DOI: 10.1385/ijgc:35:2:103

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of capecitabine plus oxal

Phase II study of capecitabine plus oxaliplatin (XELOX) as first-line treatment and followed by maintenance of capecitabine in patients with metastatic colorectal cancer

✍ Yu Hong Li; Hui Yan Luo; Feng Hua Wang; Zhi Qiang Wang; Miao Zhen Qiu; Yan Xia S 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 234 KB

Chronomodulated administration of oxalip

Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study

✍ Daniele Santini; Bruno Vincenzi; Gaia Schiavon; Marisa Di Seri; Vladimir Virzí; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 328 KB

703 PUBLICATION Phase II multicenter stu

703 PUBLICATION Phase II multicenter study of capecitabine plus oxaliplatin (XELOX) sequentially followed by capecitabine and irinotecan (XELIRI) in first-line therapy for metastatic colorectal cancer (MCRC)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 267 KB

Phase II study of short-course capecitab

Phase II study of short-course capecitabine plus oxaliplatin (XELOX) followed by maintenance capecitabine in advanced colorectal cancer: XelQuali study

✍ T. Waddell; S. Gollins; W. Soe; J. Valle; J. Allen; D. Bentley; J. Morris; A. Ll 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 448 KB

Capecitabine plus oxaliplatin (XELOX) ve

Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study

✍ Rothenberg, M. L.; Cox, J. V.; Butts, C.; Navarro, M.; Bang, Y.-J.; Goel, R.; Go 📂 Article 📅 2008 🏛 Oxford University Press 🌐 English ⚖ 149 KB

Capecitabine plus oxaliplatin (xelox) ve

Capecitabine plus oxaliplatin (xelox) versus protracted 5-fluorouracil venous infusion plus oxaliplatin (pvifox) as first-line treatment in advanced colorectal cancer: A GOAM phase II randomised study (FOCA trial)

✍ Andrea Angelo Martoni; Carmine Pinto; Francesca Di Fabio; Giorgio Lelli; Fabiola 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 176 KB